Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Sep 13, 2026
Episode
379
Soundcloud
Share
From the IASLC 2026 World Conference on Lung Cancer (WCLC) in Seoul, Dr. Narjust Florez talks with Dr. Chad Rusthoven about MAVERICK, the trial that tested MRI surveillance alone against prophylactic cranial irradiation in small cell lung cancer, and with Dr. Chul Kim about the final overall survival results of PAPILLON, amivantamab plus chemotherapy in EGFR exon 20 insertion NSCLC. Both guests share what patients and community oncologists should take from the data.
Guest
Chul Kim
MD, MPH
Thoracic Medical Oncologist and Associate Professor
Georgetown University
Chad G. Rusthoven
MD
Adjunct Associate Professor
University of Colorado
University of North Carolina at Chapel Hill
